Proteus Digital Health brings in $62.5mm through its Series F venture round
Proteus Digital Health Inc. (formerly Proteus Biomedical) has raised $62.5mm through its Series F venture round. New backer Oracle Corp. joins Otsuka Pharmaceutical Co. Ltd., Novartis AG, Sino Portfolio, and additional unnamed investors. The company has developed a digital feedback system that includes wearable and ingestible sensors to ensure that patients comply with the administration of medicine, to measure physiologic response, and overall health management.
- Monitoring Equipment & Devices
- Nanotechnology, Chips, etc.
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.